4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0000950170-25-032183
SVP, CFO acquired 3 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Daphne SVP, CFO | 2025-03-02 | Option exercise | +2 | 17 | D | ||
| Taylor Daphne SVP, CFO | 2025-03-04 | Option exercise | +1 | 18 | D | ||
| Derivatives | |||||||
| Taylor Daphne SVP, CFO | 2025-03-02 | Option exercise · Restricted Stock Unit | −2 | 2 | D | ||
| Taylor Daphne SVP, CFO | 2025-03-04 | Option exercise · Restricted Stock Unit | −1 | 0 | D | ||
Loading xslF345X05/ownership.xml…